{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T21:35:34Z","timestamp":1716932134044},"reference-count":66,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/13556210500123191","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T06:16:15Z","timestamp":1126073775000},"page":"157-164","source":"Crossref","is-referenced-by-count":23,"title":["Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone"],"prefix":"10.1111","volume":"10","author":[{"given":"J","family":"Seifert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Metzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Paetzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Borsutzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ohlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Passie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HM","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"10.1080\/13556210500123191-BIB1|cit1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J069v13n03_04","article-title":"A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification","volume":"13","author":"Amass","year":"1994","journal-title":"J Addict Dis"},{"key":"10.1080\/13556210500123191-BIB2|cit2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2003.11.002","article-title":"Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews","volume":"73","author":"Amato","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123191-BIB3|cit3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0740-5472(94)90059-0","article-title":"An open trial of low dose buprenorphine in treating methadone withdrawal","volume":"11","author":"Banys","year":"1994","journal-title":"J Subst Abuse Treat"},{"key":"10.1080\/13556210500123191-BIB4|cit4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1472-8206.2000.tb00411.x","article-title":"Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies","volume":"14","author":"Benedetti","year":"2000","journal-title":"Fundam Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1080\/13556210500123191-BIB5|cit5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000052035","article-title":"Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients Preliminary results","volume":"4","author":"Bouchez","year":"1998","journal-title":"Eur Addict Res"},{"key":"10.1080\/13556210500123191-BIB6|cit6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1192\/bjp.154.3.354","article-title":"Circumstances surrounding the initial lapse to opiate use following detoxification","volume":"154","author":"Bradley","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1080\/13556210500123191-BIB7|cit7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1080\/13556210500123191-BIB8|cit8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/299079a0","article-title":"Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor","volume":"299","author":"Corbett","year":"1982","journal-title":"Nature"},{"key":"10.1080\/13556210500123191-BIB9|cit9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(95)01171-9","article-title":"Levels and correlates of polydrug use among heroin users and regular amphetamine users","volume":"39","author":"Darke","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123191-BIB10|cit10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(81)90163-1","article-title":"Buprenorphrine: demonstration of physical dependence liability","volume":"70","author":"Dum","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"10.1080\/13556210500123191-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000052034","article-title":"Comparison of buprenorphine and methadone maintenance in opiate addicts","volume":"4","author":"Eder","year":"1998","journal-title":"Eur Addict Res"},{"key":"10.1080\/13556210500123191-BIB12|cit12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000118973","article-title":"The action of mood-stabilizers in affective disorders: an integrative view as a challenge","volume":"27","author":"Emrich","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1080\/13556210500123191-BIB13|cit13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1982.tb39483.x","article-title":"Possible antidepressive effects of opioids: action of buprenorphine","volume":"398","author":"Emrich","year":"1982","journal-title":"Ann NY Acad Sci"},{"key":"10.1080\/13556210500123191-BIB14|cit14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1990.67","article-title":"Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","volume":"47","author":"Fudala","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/13556210500123191-BIB15|cit15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02219713","article-title":"Treatment of benzodiazepine withdrawal symptoms with carbamazepine","volume":"241","author":"Garcia-Borreguero","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1080\/13556210500123191-BIB16|cit16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a Short Opiate Withdrawal Scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict Behav"},{"key":"10.1080\/13556210500123191-BIB17|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-9236(97)90155-7","article-title":"A randomized double-blind study of carbamazepine in the treatment of cocaine abuse","volume":"62","author":"Halikas","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/13556210500123191-BIB18|cit18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0306-4603(84)90003-0","article-title":"Methadone dose decreases and anxiety reduction","volume":"9","author":"Hall","year":"1984","journal-title":"Addict Behav"},{"key":"10.1080\/13556210500123191-BIB19|cit19","volume-title":"Beck-Depressions-Inventar (BDI)","author":"Hautzinger","year":"1994"},{"key":"10.1080\/13556210500123191-BIB20|cit20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: a review of its pharmacological properties and therapeutic efficacy","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"10.1080\/13556210500123191-BIB21|cit21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med"},{"key":"10.1080\/13556210500123191-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123191-BIB23|cit23","volume-title":"Die Eigenschaftsw\u00f6rterliste (EWL-K) - Ein Verfahren zur Erfassung der Befindlichkeit","author":"Janke","year":"1978"},{"key":"10.1080\/13556210500123191-BIB24|cit24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"10.1080\/13556210500123191-BIB25|cit25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.1989.147","article-title":"Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction","volume":"46","author":"Johnson","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/13556210500123191-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1080\/13556210500123191-BIB27|cit27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1176\/ajp.150.3.423","article-title":"Organic mood syndrome associated with detoxification from methadone maintenance","volume":"150","author":"Kanof","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1080\/13556210500123191-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10826089009058878","article-title":"Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison","volume":"25","author":"Kasvikis","year":"1990","journal-title":"Int J Addict"},{"key":"10.1080\/13556210500123191-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation","volume":"47","author":"Kerr","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1080\/13556210500123191-BIB30|cit30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1080\/13556210500123191-BIB31|cit31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(88)90454-7","article-title":"Buprenorphine detoxification from opioid dependence: a pilot study","volume":"42","author":"Kosten","year":"1988","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123191-BIB32|cit32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00952999108992815","article-title":"Treatment of heroin addicts using buprenorphine","volume":"17","author":"Kosten","year":"1991","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1080\/13556210500123191-BIB33|cit33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence. Growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1080\/13556210500123191-BIB34|cit34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol"},{"key":"10.1080\/13556210500123191-BIB35|cit35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1360-0443.1998.93454910.x","article-title":"Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine","volume":"93","author":"Kuhlman","year":"1998","journal-title":"Addiction"},{"key":"10.1080\/13556210500123191-BIB36|cit36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/02791072.1996.10472486","article-title":"Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal","volume":"28","author":"Latowsky","year":"1996","journal-title":"J Psychoact Drugs"},{"key":"10.1080\/13556210500123191-BIB37|cit37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13556219772732","article-title":"The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting","volume":"2","author":"Law","year":"1997","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123191-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1080\/13556210500123191-BIB39|cit39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1521-0391.1997.tb00559.x","article-title":"A protocol to switch high-dose, methadone-maintained subjects to buprenorphine","volume":"6","author":"Levin","year":"1997","journal-title":"Am J Addict"},{"key":"10.1080\/13556210500123191-BIB40|cit40","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: comparisons to methadone and placebo","volume":"70","author":"Ling","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123191-BIB41|cit41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/ajp.146.5.617","article-title":"Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal","volume":"146","author":"Malcolm","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1080\/13556210500123191-BIB42|cit42","first-page":"67","volume-title":"Jahrbuch Sucht 1998","author":"M\u00e4rkl","year":"1997"},{"key":"10.1080\/13556210500123191-BIB43|cit43","first-page":"517","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123191-BIB44|cit44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(96)90215-9","article-title":"Are detoxification programmes effective","volume":"347","author":"Mattick","year":"1996","journal-title":"Lancet"},{"key":"10.1080\/13556210500123191-BIB45|cit45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0143-4179(84)90014-3","article-title":"Physical dependence induced by opiate partial agonists in the rat","volume":"5","author":"McCarthy","year":"1984","journal-title":"Neuropeptides"},{"key":"10.1080\/13556210500123191-BIB46|cit46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.7352279","article-title":"Buprenorphine suppresses heroin use by heroin addicts","volume":"207","author":"Mello","year":"1980","journal-title":"Science"},{"key":"10.1080\/13556210500123191-BIB47|cit47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00428308","article-title":"Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study","volume":"66","author":"Okuma","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/13556210500123191-BIB48|cit48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s001150050656","article-title":"[Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms]","volume":"71","author":"Paetzold","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1080\/13556210500123191-BIB49|cit49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123191-BIB50|cit50","first-page":"99","article-title":"Dapiprazole compared with clonidine and a placebo in detoxification of opiate addicts","volume":"11","author":"Pini","year":"1991","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1080\/13556210500123191-BIB51|cit51","first-page":"490","article-title":"The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients","volume":"47","author":"Placidi","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1080\/13556210500123191-BIB52|cit52","volume-title":"Medikament - Missbrauch und Abh\u00e4ngigkeit","author":"Poser","year":"1996"},{"key":"10.1080\/13556210500123191-BIB53|cit53","first-page":"113","volume-title":"Anticonvulsants","author":"Post","year":"1994"},{"key":"10.1080\/13556210500123191-BIB54|cit54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13556210071289","article-title":"Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study","volume":"5","author":"Schneider","year":"2000","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123191-BIB55|cit55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1991.01810290060012","article-title":"Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome","volume":"48","author":"Schweizer","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1080\/13556210500123191-BIB56|cit56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2002-34115","article-title":"Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone","volume":"35","author":"Seifert","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1080\/13556210500123191-BIB57|cit57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/10826088509047754","article-title":"Methadone maintenance treatment","volume":"20","author":"Senay","year":"1985","journal-title":"Int J Addict"},{"key":"10.1080\/13556210500123191-BIB58|cit58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1986.tb128412.x","article-title":"Buprenorphine: a new maintenance opiate","volume":"144","author":"Seow","year":"1986","journal-title":"Med J Aust"},{"key":"10.1080\/13556210500123191-BIB59|cit59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1080\/13556210500123191-BIB60|cit60","first-page":"985","article-title":"Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers","volume":"261","author":"Strain","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1080\/13556210500123191-BIB61|cit61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000052036","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study","volume":"4","author":"Uehlinger","year":"1998","journal-title":"Eur Addict Res"},{"key":"10.1080\/13556210500123191-BIB62|cit62","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1248\/bpb.25.682","article-title":"Inhibition of human drug metabolizing cytochrome P450 by buprenorphine","volume":"25","author":"Umehara","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1080\/13556210500123191-BIB63|cit63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02246290","article-title":"Effects of buprenorphine and methadone in methadone-maintained subjects","volume":"119","author":"Walsh","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/13556210500123191-BIB64|cit64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"key":"10.1080\/13556210500123191-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1360-0443.1996.tb02251.x","article-title":"An evaluation of the history of a marijuana withdrawal syndrome in a large population","volume":"91","author":"Wiesbeck","year":"1996","journal-title":"Addiction"},{"key":"10.1080\/13556210500123191-BIB66|cit66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/dmd.31.6.768","article-title":"Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro","volume":"31","author":"Zhang","year":"2003","journal-title":"Drug Metab Dispos"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F13556210500123191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/13556210500123191\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T08:21:06Z","timestamp":1591863666000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/13556210500123191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1080\/13556210500123191","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}